SCHEMBL7959445

SCHEMBL7959445

Cc1ccc(-c2nc(C3=CCCCC3Cc3cccc(C(=O)O)c3)oc2-c2ccc(C)cc2)cc1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 9/20 0.86
PTGER4 P35408 5/20 0.86
PTGER1 P34995 1/20 0.86
PTGER3 P43115 1/20 0.62
RXRA P19793 2/20 0.38
RXRB P28702 2/20 0.38
CDKN1A P38936 1/20 0.37
KDM4E B2RXH2 3/20 0.36
HPGD P15428 3/20 0.36
HTT P42858 2/20 0.36
LMNA P02545 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
GAA P10253 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1626140 0.93 PTGIR (1.00) PTGIRPTGER4PTGER1PTGER3KDM4E
SCHEMBL4576000 0.93 PTGIR (1.00) PTGIRPTGER4PTGER1PTGER3KDM4E
SCHEMBL7960055 0.93 PTGIR (1.00) PTGIRPTGER4PTGER1PTGER3KDM4E
SCHEMBL7960399 0.90 PTGIR (0.94) PTGIRPTGER4PTGER1PTGER3KDM4E
SCHEMBL7961741 0.89 PTGIR (0.93) PTGIRPTGER4PTGER1PTGER3KDM4E
SCHEMBL7961736 0.89 PTGIR (0.93) PTGIRPTGER4PTGER1PTGER3KDM4E
SCHEMBL8056901 0.87 PTGIR (0.66) PTGIRPTGER4PTGER1PTGER3RXRA
SCHEMBL7949886 0.87 PTGIR (0.89) PTGIRPTGER4PTGER1PTGER3KDM4E
SCHEMBL7958123 0.87 PTGIR (0.89) PTGIRPTGER4PTGER1PTGER3KDM4E
SCHEMBL7960358 0.87 PTGER4 (0.79) PTGIRPTGER4PTGER1PTGER3RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6245790-B1 ANTIINFLAMMATORY AGENTS; GASTROINTESTINAL DISORDERS; SKN DISORDERS; BONE DISORDERS; MUSCLE RELAXANTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-06-12 US disclosed
EP-0989975-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-05 EP disclosed
WO-2000016760-A2 NEW USE OF PROSTAGLANDIN E2 ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-03-30 WO disclosed
WO-1998055468-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-10 WO disclosed